Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortization - Intangibles: 2010-2025

Historic Amortization - Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Sep 2025 value amounting to $1.0 million.

  • Cumberland Pharmaceuticals' Amortization - Intangibles fell 6.37% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 42.76%. This contributed to the annual value of $4.7 million for FY2024, which is 41.40% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Amortization - Intangibles is $1.0 million, which was up 0.31% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Amortization - Intangibles peaked at $4.5 million during Q4 2023, and registered a low of $458,222 during Q4 2022.
  • For the 3-year period, Cumberland Pharmaceuticals' Amortization - Intangibles averaged around $1.4 million, with its median value being $1.1 million (2024).
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Amortization - Intangibles surged by 890.60% in 2023 and then plummeted by 67.85% in 2024.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Amortization - Intangibles stood at $1.0 million in 2021, then slumped by 54.95% to $458,222 in 2022, then spiked by 890.60% to $4.5 million in 2023, then slumped by 67.85% to $1.5 million in 2024, then decreased by 6.37% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.0 million for Q2 2025, and $1.0 million during Q1 2025.